A robust bifidobacteria strain with excellent oxygen tolerance — the workhorse for digestive regularity and immunity in high-CFU formulations.
Key Benefit
Boosts intestinal IL‑22 production, strengthening the mucosal barrier and supporting overall gut immunity
Patent
National Invention Patent – A Lactobacillus casei strain that enhances intestinal IL‑22 expression
Commercial Use
Included in digestive health / immunity blends (formulated for digestion, bowel movement and immune support)
Why Choose CCFM1059?
Specifically targets IL‑22 – a key cytokine for intestinal defense and epithelial repair
Helps maintain gut barrier integrity, reducing susceptibility to infections and inflammation
Ideal for formulations aimed at digestive wellness, immunity, and post-antibiotic recovery
